Curcumin Suppresses Hepatic Stellate Cell-Induced Hepatocarcinoma Angiogenesis and Invasion through Downregulating CTGF

Microenvironment plays a vital role in tumor progression; we focused on elucidating the role of hepatic stellate cells (HSCs) in hepatocarcinoma (HCC) aggressiveness and investigated the potential protective effect of curcumin on HSC-driven hepatocarcinoma angiogenesis and invasion. Our data suggest that HSCs increase HCC reactive oxygen species (ROS) production to upregulate hypoxia-inducible factor-1α (HIF-1α) expression to promote angiogenesis, epithelial to mesenchymal transition (EMT) process and invasion. And HSCs could secrete soluble factors, such as interleukin-6 (IL-6), vascular endothelial cell growth factor (VEGF), and stromal-derived factor-1 (SDF-1) to facilitate HCC progression. Curcumin could significantly suppress the above HSC-induced effects in HCC and could abrogate ROS and HIF-1α expression in HCC. HIF-1α or connective tissue growth factor (CTGF) knockdown could abolish the aforementioned curcumin affection. Moreover, CTGF is a downstream gene of HIF-1α. In addition, nuclear factor E2-related factor 2 (Nrf2) and glutathione (GSH) are involved in curcumin protection of HCC. These data indicate that curcumin may induce ROS scavenging by upregulating Nrf2 and GSH, thus inhibiting HIF-1α stabilization to suppress CTGF expression to exhibit its protection on HCC. Curcumin has a promising therapeutic effect on HCC. CTGF is responsible for curcumin-induced protection in HCC.

[1]  S. Awasthi,et al.  Oxidative stress and dietary phytochemicals: Role in cancer chemoprevention and treatment. , 2018, Cancer letters.

[2]  A. Lloyd,et al.  Hypoxia as a target for drug combination therapy of liver cancer , 2017, Anti-cancer drugs.

[3]  Yue Guo,et al.  Dietary Phytochemicals and Cancer Chemoprevention: A Perspective on Oxidative Stress, Inflammation, and Epigenetics. , 2016, Chemical research in toxicology.

[4]  L. Yanqing,et al.  Notch1 promotes vasculogenic mimicry in hepatocellular carcinoma by inducing EMT signaling , 2016, Oncotarget.

[5]  Lei Cao,et al.  Curcumin inhibits H2O2-induced invasion and migration of human pancreatic cancer via suppression of the ERK/NF-κB pathway. , 2016, Oncology reports.

[6]  Wei Li,et al.  Hedgehog Signaling Activation in Hepatic Stellate Cells Promotes Angiogenesis and Vascular Mimicry in Hepatocellular Carcinoma , 2016, Cancer investigation.

[7]  Xin-yang Wang,et al.  Curcumin inhibits cancer-associated fibroblast-driven prostate cancer invasion through MAOA/mTOR/HIF-1α signaling , 2015, International journal of oncology.

[8]  A. Forner,et al.  Hepatocellular carcinoma surveillance with miRNAs. , 2015, The Lancet. Oncology.

[9]  N. Henderson,et al.  Hepatic stellate cells: central modulators of hepatic carcinogenesis , 2015, BMC Gastroenterology.

[10]  Ke-qi Han,et al.  Inflammatory microenvironment and expression of chemokines in hepatocellular carcinoma. , 2015, World journal of gastroenterology.

[11]  J. Bruix,et al.  SEARCH: a phase III, randomized, double-blind, placebo-controlled trial of sorafenib plus erlotinib in patients with advanced hepatocellular carcinoma. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  C. Weston,et al.  Vascular adhesion protein-1 promotes liver inflammation and drives hepatic fibrosis. , 2015, The Journal of clinical investigation.

[13]  J. Vadgama,et al.  Increased chemopreventive effect by combining arctigenin, green tea polyphenol and curcumin in prostate and breast cancer cells. , 2014, RSC advances.

[14]  Chun-Peng Liao,et al.  Monoamine oxidase A mediates prostate tumorigenesis and cancer metastasis. , 2014, The Journal of clinical investigation.

[15]  Liang Han,et al.  α-Mangostin inhibits hypoxia-driven ROS-induced PSC activation and pancreatic cancer cell invasion. , 2014, Cancer letters.

[16]  J. Sicklick,et al.  The glypican 3 hepatocellular carcinoma marker regulates human hepatic stellate cells via Hedgehog signaling. , 2014, The Journal of surgical research.

[17]  S. Barry,et al.  E-Cadherin and EpCAM expression by NSCLC tumour cells associate with normal fibroblast activation through a pathway initiated by integrin αvβ6 and maintained through TGFβ signalling , 2014, Oncogene.

[18]  Y Magnusson,et al.  TGF-beta receptor type-2 expression in cancer-associated fibroblasts regulates breast cancer cell growth and survival and is a prognostic marker in pre-menopausal breast cancer , 2013, Oncogene.

[19]  G. Abou-Alfa,et al.  The antiangiogenic ceiling in hepatocellular carcinoma: does it exist and has it been reached? , 2013, The Lancet. Oncology.

[20]  E. Giannoni,et al.  Stromal fibroblasts synergize with hypoxic oxidative stress to enhance melanoma aggressiveness. , 2012, Cancer letters.

[21]  Han Liu,et al.  SDF-1/CXCR4 signaling induces pancreatic cancer cell invasion and epithelial-mesenchymal transition in vitro through non-canonical activation of Hedgehog pathway. , 2012, Cancer letters.

[22]  Tom T. Chen,et al.  CCN2/Connective Tissue Growth Factor Is Essential for Pericyte Adhesion and Endothelial Basement Membrane Formation during Angiogenesis , 2012, PloS one.

[23]  J. Suh,et al.  COMP-Ang1 stimulates HIF-1α-mediated SDF-1 overexpression and recovers ischemic injury through BM-derived progenitor cell recruitment. , 2011, Blood.

[24]  E. Srivatsan,et al.  Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma , 2011, Molecular Cancer.

[25]  A. Vincent-Salomon,et al.  Oxidative stress promotes myofibroblast differentiation and tumour spreading , 2010, EMBO molecular medicine.

[26]  H. Redmond,et al.  Hypoxia increases the metastatic ability of breast cancer cells via upregulation of CXCR4 , 2010, BMC Cancer.

[27]  Bonnie F. Sloane,et al.  Fibroblast hepatocyte growth factor promotes invasion of human mammary ductal carcinoma in situ. , 2009, Cancer research.

[28]  S. Thung,et al.  Hepatic stellate cell activation in dysplastic nodules: evidence for an alternate hypothesis concerning human hepatocarcinogenesis. , 2008, Liver.

[29]  E. Srivatsan,et al.  Liposome-Encapsulated Curcumin Suppresses Growth of Head and Neck Squamous Cell Carcinoma In vitro and in Xenografts through the Inhibition of Nuclear Factor κB by an AKT-Independent Pathway , 2008, Clinical Cancer Research.

[30]  Dieter Häussinger,et al.  Sorafenib in advanced hepatocellular carcinoma. , 2008, The New England journal of medicine.

[31]  J. Iredale,et al.  Liver fibrosis: cellular mechanisms of progression and resolution. , 2007, Clinical science.

[32]  H. Moses,et al.  Stromal fibroblasts in cancer initiation and progression , 2004, Nature.

[33]  S. Lepreux,et al.  Expression and cellular localization of fibrillin-1 in normal and pathological human liver. , 2001, Journal of hepatology.

[34]  L. Howells,et al.  Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-κB activation via the NIK/IKK signalling complex , 1999, Oncogene.

[35]  D. Brenner,et al.  Curcumin blocks cytokine-mediated NF-kappa B activation and proinflammatory gene expression by inhibiting inhibitory factor I-kappa B kinase activity. , 1999, Journal of immunology.

[36]  D. Brenner,et al.  Curcumin Blocks Cytokine-Mediated NF-κB Activation and Proinflammatory Gene Expression by Inhibiting Inhibitory Factor I-κB Kinase Activity , 1999, The Journal of Immunology.

[37]  K. Mohandas,et al.  Epidemiology of digestive tract cancers in India. V. Large and small bowel. , 1999, Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology.

[38]  B. le Bail,et al.  Myofibroblasts are responsible for collagen synthesis in the stroma of human hepatocellular carcinoma: an in vivo and in vitro study. , 1999, Journal of hepatology.

[39]  D. Hanahan,et al.  Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis , 1996, Cell.

[40]  G. Semenza.  Oxygen homeostasis , 2010, Wiley interdisciplinary reviews. Systems biology and medicine.

[41]  Yoon-Koo Kang,et al.  Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial. , 2009, The Lancet. Oncology.

[42]  S. Friedman.  Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. , 2008, Physiological reviews.

[43]  B. Aggarwal,et al.  Curcumin: the Indian solid gold. , 2007, Advances in experimental medicine and biology.

[44]  D. Woodfield.  Hepatocellular carcinoma. , 1986, The New Zealand medical journal.